• Home
  • Clinical information | MyHealthTest

Clinical information

The MyHealthTest HbA1c test has been found to be comparable with traditional whole blood samples.





Our HbA1c test

MyHealthTest’s fingerprick blood test was developed by researchers from the Australian National University. Their study published in BMC Clinical Pathology in 2015 found comparable results between the MyHealthTest HbA1c (diabetes) dried blood spot test and traditional whole blood testing.

This work was also accepted at the 2015 ADS/ADEA Annual Scientific Meeting where the following poster was presented: Time-dependent effects of HbA1c levels measured through dried blood spot sampling.

The dried blood spot HbA1c test results showed a high correlation and comparable precision to conventional whole blood HbA1c test results, demonstrating that dried blood spot HbA1c testing is a viable, accurate alternative to traditional pathology methods. With imprecision <3%, dried blood spot testing is superior to many point of care HbA1c testing units.



HbA1c and diabetes diagnosis

Glycated haemoglobin, or HbA1c, is commonly measured in the management of diabetes. The test has more recently been endorsed as a diagnostic test for Type 2 diabetes by the World Health Organisation, the International Diabetes Federation and by an Australian Diabetes Society expert committee. These recommendations have been outlined in a 2012 article published in the Medical Journal of Australia.

HbA1c has now been approved for reimbursement for the diagnosis of diabetes in Australia.

More information:

Temperature stability

Testing has shown that after holding dried blood spot samples at 46 degrees C for 2 days there is a slight increase in the HbA1c level from people with an HbA1c of 7.5% and higher. Therefore, there may be a small variation in results if samples are subjected to extreme temperature conditions.